Monitoring expiratory carbon monoxide to study the effect of complete smoking cessation on definitive radiation therapy for early stage glottic carcinoma.
Shotaro TatekawaShigetoshi ShimamotoYoshiaki MiyataYutaro YoshinoTakero HirataKeisuke TamariYuji SeoFumiaki IsohashiYoshifumi YamamotoAtsuhiko UnoHidenori InoharaKazuhiko OgawaPublished in: Acta oncologica (Stockholm, Sweden) (2021)
We confirmed that the 'complete cessation' group had better prognosis than the 'no cessation' group by monitoring expiratory CO during radiation therapy for early stage glottic carcinoma. Moreover, monitoring expiratory CO was easier and more suitable than conventional methods for evaluating smoking cessation because it provided real-time measurements.